Cite
Sorror ML, Storer BE, Fathi AT, et al. Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia. Blood. 2021;138(5):387-400doi: 10.1182/blood.2020008812.
Sorror, M. L., Storer, B. E., Fathi, A. T., Brunner, A., Gerds, A. T., Sekeres, M. A., Mukherjee, S., Medeiros, B. C., Wang, E. S., Vachhani, P., Shami, P. J., Peña, E., Elsawy, M., Adekola, K., Luger, S., Baer, M. R., Rizzieri, D., Wildes, T. M., Koprivnikar, J., Smith, J., Garrison, M., Kojouri, K., Leisenring, W., Onstad, L., Nyland, J. E., Becker, P. S., McCune, J. S., Lee, S. J., Sandmaier, B. M., Appelbaum, F. R., & Estey, E. H. (2021). Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia. Blood, 138(5), 387-400. https://doi.org/10.1182/blood.2020008812
Sorror, Mohamed L, et al. "Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia." Blood vol. 138,5 (2021): 387-400. doi: https://doi.org/10.1182/blood.2020008812
Sorror ML, Storer BE, Fathi AT, Brunner A, Gerds AT, Sekeres MA, Mukherjee S, Medeiros BC, Wang ES, Vachhani P, Shami PJ, Peña E, Elsawy M, Adekola K, Luger S, Baer MR, Rizzieri D, Wildes TM, Koprivnikar J, Smith J, Garrison M, Kojouri K, Leisenring W, Onstad L, Nyland JE, Becker PS, McCune JS, Lee SJ, Sandmaier BM, Appelbaum FR, Estey EH. Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia. Blood. 2021 Aug 05;138(5):387-400. doi: 10.1182/blood.2020008812. PMID: 34351368.
Copy
Download .nbib